Fig. 1 · Structure

Documents & Downloads

Diethylstilbestrol

Cat. No. A10309 CAS 56-53-1
Diethylstilbestrol is a synthetic nonsteroidal estrogen that was first synthesized in 1938. It is also classified as an endocrine disruptor.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Diethylstilbestrol (DES) supports ERα agonist activity in a cell-free coregulator-binding assay. It increased ERα ligand-binding-domain interactions with selected NCOA1 and NCOA2 motifs. DES and estradiol produced distinct responses at some other motifs, so their coregulator profiles should not be treated as interchangeable. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Target & Activity

Target Activity Value
Estrogen receptor

Cellular Effect

Cell Line Activity Value Description Reference
CHO-K1 EC50 8.5 μM Cytotoxicity against CHO-K1 cells by Alamar blue assay [PMID: 16962325]
HEK293 EC50 0.11 nM Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay [PMID: 30940565]
HEK293 EC50 0.2 nM Agonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ER-alpha-mediated transcriptional activity by luciferase reporter gene assay [PMID: 30940565]
HepG2 IC50 14.6 μM Antagonist activity at full length human PXR transfected in human HepG2 cells assessed as reduction in rifaximin-induced receptor transactivation after 18 hrs by luciferase reporter assay [PMID: 26408814]
MCF7 IC50 0.4 nM Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay [PMID: 33257172]
Sf21 IC50 0.61 μM Displacement of [3H]-estradiol from human recombinant ERbeta expressed in Sf21 cells after 2 hrs [PMID: 22652053]
Sf21 IC50 0.77 μM Displacement of [3H]-estradiol from human recombinant ERalpha expressed in Sf21 cells after 2 hrs [PMID: 22652053]
Sf9 IC50 0.77 nM Displacement of [3H]Estradiol from human recombinant estrogen receptor alpha expressed in Sf9 cells after 2 hrs [PMID: 23403082]

Diethylstilbestrol Research Summary

This section summarizes 2 in vitro studies of Diethylstilbestrol from 1 published reference.

Diethylstilbestrol In Vitro Studies

In engineered U2OS-ERα reporter cells, DES activated luciferase expression after 24 h, with an EC50 of 8.4 pM (95% CI 7–9.9 pM). Estradiol had an EC50 of 2.5 pM (95% CI 2.3–2.9 pM), indicating greater potency in this assay. These functional EC50 values are specific to the reporter model. [1]

DES modulates ERα–coregulator motif interactions

Biochemical assay · His-tagged ERα ligand-binding domain (amino acids 302–552; 10 nM) on a PamChip array of 154 motifs from 66 coregulators [1]

DES increased ERα-LBD binding to the NCOA1 and NCOA2 motifs illustrated in Figure 3. Its pattern was not identical to E2: Figure 5 includes decreased binding to ANDR_10_32 and weak responses for several motifs strongly recruited by E2. These are motif-binding observations, not proof of full-length coregulator function or a causal explanation for toxicity.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
ERα-LBD interaction with NCOA1_1421_1441, NCOA1_677_700, NCOA2_628_651 and contrasting motifsConcentration-dependent binding Increased binding to the three NCOA motifs; decreased ANDR_10_32 binding with DES[1]

Literature-Reported Treatment Conditions

Treatment concentration
DES or E2: 10^−12–10^−5 M
Exposure duration
80 array cycles at two cycles/minute
Method
ERα-LBD interaction with immobilized coregulator motifs at 20 °C
Vehicle
2% DMSO; 2% DMSO alone was the negative control
Reported limits
Independent replicate count and uncertainty definition are not specified in the main-text coregulator assay section or Figures 3/5 captions. Supplementary concentration-response data were not retrieved.
Methods and source locations

Compound reported in the paper: Diethylstilbestrol; Compound label in the paper: DES

Findings apply to the DES material and assay reported in this paper; they do not validate an Adooq lot.

Materials and methods: Coregulator binding assay; Results: ERα-mediated coregulator motif binding and comparison; Figures 3 and 5 with captions

ERα-LBD interaction with NCOA1_1421_1441, NCOA1_677_700, NCOA2_628_651 and contrasting motifs: Fluorescence-based MARCoNI peptide microarray; solvent control and E2 comparator — Figures 3 and 5; Results: ERα-mediated coregulator motif binding and comparison of DES/E2; Materials and methods: Coregulator binding assay

ERα reporter activation by DES

Cell-based study · Human U2OS osteosarcoma cells stably expressing ERα and a 3×ERE-TATA-luciferase reporter [1]

DES induced luciferase expression with a reported EC50 of 8.4 pM (95% CI 7–9.9), compared with 2.5 pM (95% CI 2.3–2.9) for E2. DES was less potent in this assay. Responses were normalized to the maximum E2 response; Figure 2a reports means ± SD of three independent experiments.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
ERα-mediated luciferase reporter induction by DESEC50 8.4 pM (95% confidence interval 7–9.9 pM)[1]
ERα-mediated luciferase reporter induction by the E2 comparatorEC50 2.5 pM (95% confidence interval 2.3–2.9 pM)[1]

Literature-Reported Treatment Conditions

Treatment concentration
DES or E2: 0.1–100 pM
Exposure duration
24 h exposure
Method
U2OS-ERα luciferase assay in phenol-red-free DMEM/F12 with charcoal-treated serum; exposures performed in triplicate
Vehicle
DMSO, maximum 0.5% in exposure medium
Reported limits
No ERα-null or antagonist-blockade control is described for this reporter experiment. EC50 is a functional assay endpoint, not a binding affinity or treatment recommendation.
Methods and source locations

Compound reported in the paper: Diethylstilbestrol; Compound label in the paper: DES

Findings apply to the DES material and assay reported in this paper; they do not validate an Adooq lot.

Materials and methods: Cell lines and culture conditions; Reporter gene assay; Results: Activation of ERα-mediated gene expression; Figure 2a and Table 1

ERα-mediated luciferase reporter induction by DES: Luciferase activity, normalized to maximum E2 response — Table 1, U2OS-ERα reporter gene expression row; Figure 2a and caption

ERα-mediated luciferase reporter induction by the E2 comparator: Same reporter assay; E2 separate from DES — Table 1, U2OS-ERα reporter gene expression row

Specifications

Manufacturer Adooq Bioscience
CAS Number 56-53-1
Formula C18H20O2
Molecular Weight 268.35
Synonyms Diethylstilboestrol; DES; BAN stilboestrol
SMILES
CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 50 mg/mL (186.31 mM)
Water Insoluble
Ethanol 50 mg/mL (186.31 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Diethylstilbestrol Research References

  1. [1] Aziza Hussein Bakheit Adam, Laura H. J. de Haan, Ignacio Miro Estruch, et al. Estrogen receptor alpha (ERα)–mediated coregulator binding and gene expression discriminates the toxic ERα agonist diethylstilbestrol (DES) from the endogenous ERα agonist 17β-estradiol (E2) Cell Biology and Toxicology (2020). PMID: 32088792 DOI: 10.1007/s10565-020-09516-6 Source material

Added to your cart

View Cart Checkout
Loading...